Outcomes of immunosuppression in IGA nephropathy based on the oxford classification

Abstract EN

Numerous studies have addressed the predictive value of pathology findings from the Oxford Classification.

Whether this influences treatment choice has not been determined.

We evaluated patients with IgA nephropathy who were immunosuppressed and correlated our findings with both clinical and histological features as per the Oxford Classification.

This was a retrospective observational study of 45 patients who had biopsy-proven IgA nephropathy with a mean follow-up of 2.6 years.

Primary outcomes were time to end-stage renal disease (ESRD) or a 50% rise in serum creatinine.

Immunosuppression was not associated with lower hazards for both ESRD and 50% rise in serum creatinine.

From the Oxford Classification, only T0 was associated with significantly lower hazards for ESRD [hazard ratio (HR), 0.067; confidence interval (CI) 0.01–0.58].

Patients who had crescents and/or necrotizing lesions on biopsy were more likely to be immunosuppressed (odds ratio 9.99; 95% CI 1.99–50.06, P = 0.005) but demonstrated a statistically nonsignificant higher hazard for both renal end points (HR, 1.61; CI 0.19–13.89).

Such lesions were also associated with a higher incidence of hypertension (149 vs.

135 mm Hg) and greater proteinuria (2.7 vs.

1.9 g/day) at presentation.

The use of the Oxford Classification did not aid decision-making with regard to the use of immunosuppression.

Crescents and/or necrosis identified on histology were associated with the use of immunosuppression.

Hence, there is a need for these lesions to be evaluated further in large cohorts and incorporated into future disease classifications.